Shareholders Clear the Way for a Distressed Debt Exchange, Approving a 4 Billion Share Authorization and Reverse Split

summarizeSummary

Shareholders approved a 4 billion share authorization, a restated equity plan, and a potential reverse stock split, enabling the distressed debt exchange and setting the stage for extreme dilution.

check_boxKey Events · Corporate Governance and Compliance · GOSS

• Authorized Shares Surge to 4 Billion

  A Charter Amendment boosting authorized common shares from 700 million to 4 billion—a nearly 6x increase—was approved, providing the headroom needed for conversions tied to the distressed debt exchange and the restated equity plan.

• Debt Exchange Share Issuance Approved

  Stockholders gave the green light for the potential issuance of shares upon conversion of up to $72 million in New Convertible Notes and the exercise of 135,789,000 Purchase Warrants, an amount exceeding 20% of the pre-exchange outstanding shares.

• Reverse Stock Split Authorized

  A series of 30 alternate reverse split amendments was approved, granting the board discretion to implement a reverse split to address the $0.14 stock price and Nasdaq listing requirements.

• Equity Plan Restated

  The 2019 Incentive Award Plan was amended and restated to increase the share reserve, with the overall limit now including 10% of post-transaction fully-diluted shares and annual evergreen increases starting in 2027.

auto_awesomeAnalysis · GOSS · Life Sciences

In a sweeping vote, shareholders have removed the final hurdle to Gossamer Bio's distressed debt restructuring. The authorized share count leaps from 700 million to 4 billion, creating the capacity to convert $181 million of existing notes into equity and warrants. The approval also hands the board a powerful tool—a potential reverse stock split—to combat the stock's $0.14 price and satisfy Nasdaq listing requirements. While these votes finalize the debt exchange that closed in June, they also pave the way for extreme dilution: the new authorized share count is nearly 10 times the current outstanding shares, and the 135.8 million warrants alone represent a massive overhang. For a company carrying a going concern warning and a market cap under $70 million, this survival maneuver will fundamentally reshape its capitalization.